Playback speed
10 seconds
NAMS 2024 Insights: Efficacy of Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause: Phase 3 Study
207 views
September 19, 2024
Login to view comments.
Click here to Login